Schedule of the Error Correction (Details) - USD ($) |
3 Months Ended | 6 Months Ended | ||
---|---|---|---|---|
Jun. 30, 2024 |
Jun. 30, 2023 |
Jun. 30, 2024 |
Jun. 30, 2023 |
|
Research and development expense | $ 645,719 | $ 839,665 | $ 1,231,823 | $ 1,761,466 |
General and administrative expense | $ 310,038 | 209,279 | $ 634,647 | 464,633 |
Total | 2,226,099 | |||
Previously Reported [Member] | ||||
Research and development expense | 1,944,181 | |||
General and administrative expense | 281,918 | |||
Total | 2,226,099 | |||
Revision of Prior Period, Error Correction, Adjustment [Member] | ||||
Research and development expense | (182,715) | |||
General and administrative expense | $ 93,708 | 182,715 | ||
Total |
X | ||||||||||
- Definition The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|